The Big Vitamin D Mistake

다국어 초록 (Multilingual Abstract)

Since 2006, type 1 diabetes in Finland has plateaued and then decreased after the authorities’ decision to fortify dietary milk products with cholecalciferol. The role of vitamin D in innate and adaptive immunity is critical. A statistical error in the estimation of the recommended dietary allowance (RDA) for vitamin D was recently discovered; in a correct analysis of the data used by the Institute of Medicine, it was found that 8895 IU/d was needed for 97.5% of individuals to achieve values ≥50 nmol/L. Another study confirmed that 6201 IU/d was needed to achieve 75 nmol/L and 9122 IU/d was needed to reach 100 nmol/L. The largest meta-analysis ever conducted of studies published between 1966 and 2013 showed that 25-hydroxyvitamin D levels <75 nmol/L may be too low for safety and associated with higher all-cause mortality, demolishing the previously presumed U-shape curve of mortality associated with vitamin D levels. Since all-disease mortality is reduced to 1.0 with serum vitamin D levels ≥100 nmol/L, we call public health authorities to consider designating as the RDA at least three-fourths of the levels proposed by the Endocrine Society Expert Committee as safe upper tolerable daily intake doses. This could lead to a recommendation of 1000 IU for children <1 year on enriched formula and 1500 IU for breastfed children older than 6 months, 3000 IU for children >1 year of age, and around 8000 IU for young adults and thereafter. Actions are urgently needed to protect the global population from vitamin D deficiency.

참고문헌 (Reference)

1 Karvonen M, "The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group" 22 (22): 1066-1070, 1999

2 van Halteren AG, "Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3)" 51 (51): 2119-2125, 2002

3 Papadimitriou DT, "Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol" 5 (5): 344-348, 2013

4 Garland CF, "Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D" 104 (104): e43-e50, 2014

5 Heaney R, "Letter to Veugelers, P.J. and Ekwaru, J.P., A statistical error in the estimation of the recommended dietary allowance for vitamin D. Nutrients 2014, 6, 4472-4475; doi:10.3390/nu6104472" 7 (7): 1688-1690, 2015

6 Hypponen E, "Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study" 358 (358): 1500-1503, 2001

7 Kampmann U, "Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency: a double-blind, randomized, placebo-controlled trial" 63 (63): 1115-1124, 2014

8 Makinen M, "An increase in serum 25-hydroxyvitamin D concentrations preceded a plateau in type 1 diabetes incidence in Finnish children" 99 (99): E2353-E2356, 2014

9 Veugelers PJ, "A statistical error in the estimation of the recommended dietary allowance for vitamin D" 6 (6): 4472-4475, 2014

10 Riek AE, "25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes" 144 (144): 172-179, 2014